Cambridge Investment Research Advisors
OTIC

Cambridge Investment Research Advisors’s Otonomy, Inc. OTIC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-76,720
Closed -$160K – 3187
2022
Q2 		$160K Sell
76,720
-700
-0.9% -$1.46K ﹤0.01% 2779
2022
Q1 		$186K Sell
77,420
-8,450
-10% -$18K ﹤0.01% 2896
2021
Q4 		$179K Hold
85,870
– – ﹤0.01% 2923
2021
Q3 		$165K Hold
85,870
– – ﹤0.01% 2858
2021
Q2 		$191K Sell
85,870
-2,500
-3% -$5.78K ﹤0.01% 2850
2021
Q1 		$225K Buy
88,370
+5,650
+7% +$23.2K ﹤0.01% 2518
2020
Q4 		$535K Buy
82,720
+42,080
+104% +$191K ﹤0.01% 1728
2020
Q3 		$165K Buy
40,640
+25,500
+168% +$96.1K ﹤0.01% 2297
2020
Q2 		$55K Buy
15,140
+3,500
+30% +$9.11K ﹤0.01% 2375
2020
Q1 		$23K Buy
+11,640
New +$35.9K ﹤0.01% 2235

Other funds holding OTIC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Cambridge Investment Research Advisors's OTIC Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 76,720 shares — an estimated $160K sold.

Cambridge Investment Research Advisors first reported a position in OTIC in Q1 2020 and held it in 10 quarters. The position peaked at $535K in Q4 2020. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 76,720 Otonomy, Inc. shares in Q3 2022, an estimated $160K.
  • Cambridge Investment Research Advisors first reported a position in Otonomy, Inc. in Q1 2020 and held it in 10 quarters.
  • Cambridge Investment Research Advisors's Otonomy, Inc. position peaked at $535K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.